SYSTEMATIC PROCESSING OF FULL GENOMIC ANALYSIS OF THE ANAVEX®2-73 PHASE 2A ALZHEIMER’S DISEASE STUDY IDENTIFIES BIOMARKERS ENABLING A PRECISION MEDICINE APPROACH